GF Fund Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45.7K Buy
1,724
+139
+9% +$3.6K ﹤0.01% 403
2026
Q2
$41.4K Sell
1,585
-96
-6% -$2.44K ﹤0.01% 410
2026
Q1
$42.1K Buy
1,681
+211
+14% +$4.99K ﹤0.01% 417
2025
Q4
$38.7K Sell
1,470
-147
-9% -$3.21K ﹤0.01% 427
2025
Q3
$27.6K Sell
1,617
-146
-8% -$2.09K ﹤0.01% 451
2025
Q2
$22.1K Hold
1,763
– – ﹤0.01% 492
2025
Q1
$21K Buy
1,763
+317
+22% +$4.32K ﹤0.01% 498
2024
Q4
$21.2K Buy
+1,446
New +$20.2K ﹤0.01% 467

Other funds holding ZYME

GF Fund Management's ZYME Position: Q3 2026 in Review

GF Fund Management increased its Zymeworks (ZYME) stake by 8.8% in Q3 2026, buying an estimated $3.6K and bringing the position to 1,724 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #403.

GF Fund Management first reported a position in ZYME in Q4 2024 and has held it in 8 quarters since. 132 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • GF Fund Management held 1,724 shares of Zymeworks worth $45.7K as of Q3 2026.
  • GF Fund Management bought 139 Zymeworks shares in Q3 2026, an estimated $3.6K.
  • Zymeworks made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #403 holding.
  • GF Fund Management first reported a position in Zymeworks in Q4 2024 and has held it in 8 quarters since.
  • 132 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.